Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Other Operating Expenses (2016 - 2025)

Cross Country Healthcare's Other Operating Expenses history spans 16 years, with the latest figure at $255.8 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 0.66% year-over-year to $255.8 million; the TTM value through Dec 2025 reached $934.5 million, down 16.8%, while the annual FY2025 figure was $934.3 million, 16.82% down from the prior year.
  • Other Operating Expenses reached $255.8 million in Q4 2025 per CCRN's latest filing, up from $207.6 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $620.8 million in Q1 2022 to a low of $207.6 million in Q3 2025.
  • Average Other Operating Expenses over 5 years is $359.4 million, with a median of $304.4 million recorded in 2024.
  • Peak YoY movement for Other Operating Expenses: soared 203.26% in 2021, then plummeted 36.85% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $497.9 million in 2021, then decreased by 0.35% to $496.1 million in 2022, then plummeted by 33.04% to $332.2 million in 2023, then fell by 22.48% to $257.5 million in 2024, then fell by 0.66% to $255.8 million in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Other Operating Expenses are $255.8 million (Q4 2025), $207.6 million (Q3 2025), and $229.3 million (Q2 2025).